Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Urol Case Rep ; 27: 100918, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31687354

ABSTRACT

We describe a case of an isolated injury to the left distal corpus cavernosum from a bullet involving the glans penis, an injury location not previously described in the literature. This case illustrates the importance of performing an artificial erection test during penile exploration and the focal nature of civilian gunshot wounds. If a bullet wound is obviously superficial to either the urethra or erectile bodies, conservative management is acceptable. While retrograde urethrogram or flexible cystoscopy is warranted to rule out urethral injury, immediate operative exploration is recommended in cases suspicious for corporal defects due to limitations of diagnostic testing.

2.
J Endourol Case Rep ; 4(1): 32-34, 2018.
Article in English | MEDLINE | ID: mdl-29588918

ABSTRACT

Triplication of the ureter is a rare urologic finding that has been well described in the literature. Patients can present with urinary tract infections, incontinence, and calculi. We present the case of a patient with extensive stone burden with right trifid and left bifid collecting systems. Stone management was performed with a multimodal approach using a combination of endoscopic and percutaneous approaches. Our systematic and staged approach highlights a method for efficacious stone treatment in a complex endourologic case.

3.
Nat Cell Biol ; 16(11): 1069-79, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25327288

ABSTRACT

Cells rely on autophagy to clear misfolded proteins and damaged organelles to maintain cellular homeostasis. In this study we use the new autophagy inhibitor PIK-III to screen for autophagy substrates. PIK-III is a selective inhibitor of VPS34 that binds a unique hydrophobic pocket not present in related kinases such as PI(3)Kα. PIK-III acutely inhibits autophagy and de novo lipidation of LC3, and leads to the stabilization of autophagy substrates. By performing ubiquitin-affinity proteomics on PIK-III-treated cells we identified substrates including NCOA4, which accumulates in ATG7-deficient cells and co-localizes with autolysosomes. NCOA4 directly binds ferritin heavy chain-1 (FTH1) to target the iron-binding ferritin complex with a relative molecular mass of 450,000 to autolysosomes following starvation or iron depletion. Interestingly, Ncoa4(-/-) mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells. Taken together, the results of this study provide a new mechanism for selective autophagy of ferritin and reveal a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo.


Subject(s)
Autophagy/physiology , Class III Phosphatidylinositol 3-Kinases/antagonists & inhibitors , Ferritins/metabolism , Homeostasis/physiology , Iron/metabolism , Nuclear Receptor Coactivators/metabolism , Animals , Autophagy/drug effects , Cells, Cultured , Humans , Lysosomes/metabolism , Mice , Phagosomes/metabolism , Protein Binding
4.
Methods Mol Biol ; 795: 161-77, 2012.
Article in English | MEDLINE | ID: mdl-21960222

ABSTRACT

Quantitative chemoproteomics has recently emerged as an experimental approach to determine protein interaction profiles of small molecules in a given cell line or tissue. In contrast to standard biochemical and biophysical kinase assays, application of this method to kinase inhibitors determines compound binding to endogenously expressed kinases under conditions approximating the physiological situation with regard to the molecular state of the kinase and presence of required cofactors and regulatory proteins. Using a dose-dependent, competition-based experimental design in combination with quantitative mass spectrometry approaches, such as the use of tandem mass tags (TMT) for isobaric labeling described here, allows to rank-order interactions of inhibitors to kinase by binding affinity.


Subject(s)
Enzyme Assays/methods , Enzyme Inhibitors/chemistry , Phosphotransferases/metabolism , Proteomics/methods , Binding, Competitive , Cell Line, Tumor , Chromatography, Affinity , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , HeLa Cells , Humans , K562 Cells , Mass Spectrometry , Peptides/metabolism , Phosphotransferases/antagonists & inhibitors , Protein Binding/drug effects , Staining and Labeling
5.
Nat Chem Biol ; 7(9): 639-47, 2011 Aug 07.
Article in English | MEDLINE | ID: mdl-21822274

ABSTRACT

Cephalostatin 1, OSW-1, ritterazine B and schweinfurthin A are natural products that potently, and in some cases selectively, inhibit the growth of cultured human cancer cell lines. The cellular targets of these small molecules have yet to be identified. We have discovered that these molecules target oxysterol binding protein (OSBP) and its closest paralog, OSBP-related protein 4L (ORP4L)--proteins not known to be involved in cancer cell survival. OSBP and the ORPs constitute an evolutionarily conserved protein superfamily, members of which have been implicated in signal transduction, lipid transport and lipid metabolism. The functions of OSBP and the ORPs, however, remain largely enigmatic. Based on our findings, we have named the aforementioned natural products ORPphilins. Here we used ORPphilins to reveal new cellular activities of OSBP. The ORPphilins are powerful probes of OSBP and ORP4L that will be useful in uncovering their cellular functions and their roles in human diseases.


Subject(s)
Biological Products/pharmacology , Cholestenones/pharmacology , Neoplasms/metabolism , Phenazines/pharmacology , Receptors, Steroid/metabolism , Saponins/pharmacology , Spiro Compounds/pharmacology , Steroids/pharmacology , Biological Products/antagonists & inhibitors , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cholestenones/antagonists & inhibitors , Humans , Hydroxycholesterols/pharmacology , Lipid Metabolism/drug effects , Phenazines/antagonists & inhibitors , Receptors, Steroid/genetics , Saponins/antagonists & inhibitors , Signal Transduction/drug effects , Sphingomyelins/biosynthesis , Spiro Compounds/antagonists & inhibitors , Steroids/antagonists & inhibitors , Stilbenes/antagonists & inhibitors , Stilbenes/pharmacology
6.
World J Surg ; 32(11): 2403-7, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18716829

ABSTRACT

BACKGROUND: The potential for massive hemorrhage imposes additional challenge in the management of retroperitoneal tumors. This report details technical considerations for the management of upper retroperitoneal tumors using principles of liver transplantation. METHODS: A retrospective chart review of patients who underwent surgery for extensive retroperitoneal tumors using techniques for liver transplantation from December 2002 to November 2007 was done. RESULTS: Twenty-four patients (14 males and 10 females with a mean age 57 years) underwent major retroperitoneal surgery. Renal cell carcinoma was the most common tumor seen in 17 patients. Mean tumor dimension was 12.4 cm. Abdominal exposure was achieved via bilateral subcostal incision with upper midline extension. Right hepatic lobe mobilization and isolation from the inferior vena cava (IVC) was performed in 23 cases. Fourteen patients had IVC involvement by tumor thrombus, which was infrahepatic in six, retrohepatic in five, and intra-atrial in three patients. Tumor thrombus was removed by cavotomy in seven cases, resection and plasty in four cases, IVC graft reconstruction in two cases, and one patient required IVC and atrial graft reconstruction. Liver resection was needed in seven patients to achieve R0 resection. The Pringle maneuver was used in three patients; total liver vascular isolation with venovenous bypass was required in two cases, transdiaphragmatic intrapericardial IVC control in one case, and cardiopulmonary bypass in one patient. There was no intraoperative or postoperative mortality and mean length of stay was 13 days. CONCLUSION: Liver transplantation surgical principles help achieve exposure and vascular control of major vascular structures that enable safe resection of these extensive retroperitoneal tumors.


Subject(s)
Carcinoma/surgery , Hemostasis, Surgical/methods , Hepatectomy/methods , Liver Transplantation/methods , Retroperitoneal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Carcinoma/diagnostic imaging , Carcinoma/pathology , Cohort Studies , Female , Humans , Male , Middle Aged , Radiography , Retroperitoneal Neoplasms/diagnostic imaging , Retroperitoneal Neoplasms/pathology , Retrospective Studies , Survival Analysis , Treatment Outcome , Vena Cava, Inferior/pathology , Vena Cava, Inferior/surgery
7.
Inflammopharmacology ; 12(5-6): 521-34, 2005.
Article in English | MEDLINE | ID: mdl-16259719

ABSTRACT

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to treat inflammation and to provide pain relief but suffer from a major liability concerning their propensity to cause gastric damage. As nitric oxide (NO) is known to be gastro-protective we have synthesized a NO-donating prodrug of naproxen named NMI-1182. We evaluated two cyclo-oxygenase (COX)-inhibiting nitric oxide donors (CINODs), NMI-1182 and AZD3582, for their ability to be gastro-protective compared to naproxen and for their anti-inflammatory activity. NMI-1182 and AZD3582 were found to produce similar inhibition of COX activity to that produced by naproxen. Both NMI-1182 and AZD3582 produced significantly less gastric lesions after oral administration than naproxen. All three compounds effectively inhibited paw swelling in the rat carrageenan paw edema model. In the carrageenan air pouch model all three compounds significantly reduced PGE2 levels in the pouch exudate but only NMI-1182 and naproxen inhibited leukocyte influx. These data demonstrate that NMI-1182 has comparable anti-inflammatory activity to naproxen but with a much reduced likelihood to cause gastric damage.


Subject(s)
Cyclooxygenase Inhibitors/pharmacology , Naphthalenes/pharmacology , Nitric Oxide Donors/pharmacology , Protective Agents/pharmacology , Animals , Anti-Inflammatory Agents/blood , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Aorta, Abdominal/drug effects , Aorta, Abdominal/physiology , Carrageenan , Cyclooxygenase 1/blood , Cyclooxygenase 2/blood , Cyclooxygenase Inhibitors/blood , Cyclooxygenase Inhibitors/chemistry , Dinoprostone/antagonists & inhibitors , Dinoprostone/metabolism , Dose-Response Relationship, Drug , Edema/chemically induced , Edema/prevention & control , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Humans , In Vitro Techniques , Inflammation/chemically induced , Inflammation/prevention & control , Male , Molecular Structure , Naphthalenes/blood , Naphthalenes/chemistry , Naproxen/blood , Naproxen/chemistry , Naproxen/pharmacology , Neutrophil Infiltration/drug effects , Nitric Oxide Donors/blood , Nitric Oxide Donors/chemistry , Protective Agents/chemistry , Rats , Rats, Sprague-Dawley , Vasodilation/drug effects
8.
Free Radic Biol Med ; 39(9): 1191-207, 2005 Nov 01.
Article in English | MEDLINE | ID: mdl-16214035

ABSTRACT

Nitric oxide (NO) enhances anti-inflammatory drug action. Through a metabonomics approach termed "NObonomics," the effects of a prototypic NO donor (organic nitrate)-cyclooxygenase-2 inhibitor hybrid (NO-coxib), NMI-1093, on the NO metabolite status of the circulation and major organs have been profiled in vivo in the rat. An oral anti-inflammatory NMI-1093 bolus elicited acute tissue-, time-, and dose-dependent changes in oxidative and nitroso/nitrosyl NO metabolites. Gastric N-nitrosation and hepatic S-nitrosation and heme nitrosylation emerged as sensitive indices of this NO-coxib's metabolism. Acute NMI-1093-induced nitros(yl)ation correlated positively as a function of nitrate plus nitrite formation across all organs examined, suggesting a unifying in vivo mechanism consequent to NMI-1093 biotransformation that links oxidative and nitros(yl)ative routes of NO chemical biology and thereby may support downstream NO signaling. NMI-1093 depressed erythrocyte nitros(yl)ation, likely by inhibiting cellular carbonic anhydrase and shifting the intracellular balance between nitrogen oxides and carbonates. Glutathione-S-transferase or cytochrome P450 inhibitors also attenuated NMI-1093's NO metabolism in a compartment-selective fashion. Although not itself a NO donor, the des-nitro coxib analog of NMI-1093 influenced basal NO metabolite profiles, implicating a cyclooxygenase-NO synthase interaction in physiological NO regulation. By detailing the global NO metrics of a unique coxib bearing a popular NO-donor pharmacophore (i.e., a nitrate moiety) and defining some critical mechanistic determinants, this study demonstrates how NObonomics can serve as valuable tool in helping elucidate NO systems biology and the effect of NO-donor and non-NO-donating therapeutics thereon.


Subject(s)
Cyclooxygenase 2 Inhibitors/pharmacology , Nitrates/metabolism , Nitric Oxide Donors/pharmacology , Nitric Oxide/metabolism , Nitrites/metabolism , Animals , Brain/drug effects , Brain/metabolism , Carbonic Anhydrases/drug effects , Cyclooxygenase 2 Inhibitors/administration & dosage , Cyclooxygenase 2 Inhibitors/chemistry , Dose-Response Relationship, Drug , Erythrocytes/enzymology , Gastric Mucosa/metabolism , Heme/metabolism , Kidney/drug effects , Kidney/metabolism , Liver/drug effects , Liver/metabolism , Male , Nitric Oxide Donors/administration & dosage , Nitric Oxide Donors/chemistry , Oxazoles/administration & dosage , Oxazoles/chemistry , Oxazoles/pharmacology , Oxidation-Reduction , Rats , Rats, Sprague-Dawley , Stomach/drug effects , Sulfonamides/administration & dosage , Sulfonamides/chemistry , Sulfonamides/pharmacology
9.
J Med Chem ; 48(11): 3930-4, 2005 Jun 02.
Article in English | MEDLINE | ID: mdl-15916445

ABSTRACT

Incorporation of a spacer group between the central scaffold and the aryl ring resulted in a new cyclooxygenase-2 (COX-2) selective inhibitor core structure, 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone (20), with COX-2 IC50 = 0.25 microM and COX-1 IC50 = 14 microM (human whole blood assay). Compound 20 was orally active in the rat air pouch model of inflammation, inhibiting white blood cell infiltration and COX-2-derived PG production. Our data support the identification of a novel COX-2 selective inhibitor core structure exemplified by 20.


Subject(s)
Cyclooxygenase Inhibitors/chemical synthesis , Prostaglandin-Endoperoxide Synthases/metabolism , Pyridines/chemical synthesis , Sulfones/chemical synthesis , Administration, Oral , Animals , Carrageenan , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/chemistry , Cyclooxygenase Inhibitors/pharmacology , Dinoprostone/antagonists & inhibitors , Dinoprostone/biosynthesis , Inflammation/chemically induced , Inflammation/metabolism , Male , Pyridines/chemistry , Pyridines/pharmacology , Rats , Rats, Sprague-Dawley , Sulfones/chemistry , Sulfones/pharmacology
10.
Proc Natl Acad Sci U S A ; 101(48): 16958-63, 2004 Nov 30.
Article in English | MEDLINE | ID: mdl-15550545

ABSTRACT

Nitric oxide (NO)-derived products may modify tissue constituents, forming S- and N-nitroso adducts and metal nitrosyls implicated in NO signaling. Nitrovasodilator drugs have been in widespread use for more than a century, yet their biotransformation pathways to NO and their effects as NO donors across tissues remain ill defined. By using a metabonomics approach (termed "NObonomics") for detailing the global NO-related metabolism of the cornerstone nitrovasodilator, glyceryl trinitrate (GTN; 0.1-100 mg/kg), in the rat in vivo, we find that GTN biotransformation elicits extensive tissue nitros(yl)ation throughout all major organ systems. The corresponding reaction products remained detectable hours after administration, and vascular tissue was not a major nitros(yl)ation site. Extensive heart and liver modifications involved both S- and N-nitrosation, and RBC S-nitrosothiol formation emerged as a sensitive indicator of organic nitrate metabolism. The dynamics of GTN-derived oxidative NO metabolites in blood did not reflect the nitros(yl)ation patterns in the circulation or in tissues, casting doubt on the usefulness of plasma nitrite/nitrate as an index of NO/NO-donor biodynamics. Target-tissue NO metabolites varied in amount and type with GTN dose, suggesting a dose-sensitive shift in the prevailing routes of GTN biotransformation ("metabolic shunting") from thiol nitrosation to heme nitrosylation. We further demonstrate that GTN-induced nitros(yl)ation is modulated by a complex, tissue-selective interplay of enzyme-catalyzed pathways. These findings provide insight into the global in vivo metabolism of GTN at pharmacologically relevant doses and offer an additional experimental paradigm for the NObonomic analysis of NO-donor metabolism and signaling.


Subject(s)
Nitric Oxide/metabolism , Nitroglycerin/pharmacokinetics , Animals , Biotransformation , Dose-Response Relationship, Drug , Male , Nitric Oxide Donors/administration & dosage , Nitroglycerin/blood , Rats , Rats, Wistar
11.
Bioorg Med Chem Lett ; 14(24): 6049-52, 2004 Dec 20.
Article in English | MEDLINE | ID: mdl-15546727

ABSTRACT

A series of 3-(2-methoxytetrahydrofuran-2-yl)pyrazoles (4-10) was synthesized. The compounds were evaluated for their ability to inhibit cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) activity in human whole blood (HWB). The compound, 5-(4-methanesulfonylphenyl)-3-(2-methoxytetrahydrofuran-2-yl)-1-p-tolyl-1H-pyrazole 5 showed potent and selective COX-2 inhibition (IC50 for COX-1: >100 microM and COX-2: 1.2 microM).


Subject(s)
Cyclooxygenase Inhibitors/pharmacology , Prostaglandin-Endoperoxide Synthases/drug effects , Pyrazoles/pharmacology , Cyclooxygenase 1 , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/chemical synthesis , Cyclooxygenase Inhibitors/chemistry , Drug Evaluation, Preclinical , Humans , Isoenzymes/antagonists & inhibitors , Membrane Proteins , Molecular Structure , Prostaglandin-Endoperoxide Synthases/blood , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...